Yunnan Creates One Of China's Largest Biopharma Pilot Production Centers
This article was originally published in PharmAsia News
Executive Summary
The Yunnan Institute of Materia Medica has established a series of R&D platforms, notably China's largest biopharma pilot production centerYou may also be interested in...
Orchard’s Gene Therapy Under Fast-Track Review At EMA
A handful of new products are under review at the European Medicines Agency. Orchard Therapeutics' gene therapy application will be fast-tracked; Roche's filing for its new flu treatment will not.
Ipsen’s Palovarotene Hit By FDA Clinical Hold
The US FDA has slapped a partial clinical hold on Ipsen’s palovarotene clinical trials in rare bone disorders in children less than 14 years old, due to bone growth concerns.
Venture Funding Deals: Sumitomo Alliance With Roivant Takes Shape
Derived from Strategic Transactions, Informa’s premium source for tracking life sciences deal activity, the Venture Funding Deals column provides a comprehensive monthly review of emerging biopharmaceutical companies that have received venture funding. This month’s column covers deals announced October to November.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports